If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Market Research, Analytics and Forecasting » Analytics
Download FREE Excerpt
13 Info Graphics
19 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The biopharmaceutical industry has seen an explosion in the availability of Big Data that can generate valuable insights for the Medical Affairs function. However, the inherent costs and other challenges have caused the biopharmaceutical sector to embrace Big Data analytics slower than other industries.
Best Practices, LLC undertook this study to better understand the structure and governance approaches the biopharmaceutical sector is taking insofar as Big Data utilization by the medical affairs function. In addition, the study investigates the types of Big Data studies, the most valued partnerships and the policies that companies are using as they move to a more analytically based approach to medical decisions.
Best Practices engaged 12 leaders from 11 pharmaceutical companies through a benchmark survey in regards to Big Data usage in Medical Affairs. Research analysts also conducted seven deep-dive interviews with selected benchmark participants.